Posted in | News | Gold | Silver | Mining Business

Firma Joint Venture Begins Processing of Mineralized Tailings at Aldama Plant

Firma Holdings Corp. (OTC PINK: FRMA), through its subsidiary GracePoint Mining Corp, is pleased to announce that, in its partnership with Atlas Minerals Holdings II, the processing of mineralized tailings has begun at the Aldama Plant, located in Aldama, Chihuahua.

Additionally, the Joint Venture is pleased to announce that is has acquired control of 50,000 tonnes of tailings with gold / silver values that appear to be economic, based on limited initial sampling and recover-rate testing.

Processing at the Aldama Merrill Crowe processing plant will start a pilot-test run of tailings at the rate of 40 tonnes per day. If the gold and silver grades contained in the tailings confirm the vender's representations and the results of Gracepoint's limited initial sampling, the plant will continue to process these tailings until it reaches its full estimated "Phase 1" throughput capacity of 2,000 tonnes per month, which should occur before the end of the second month of operation.

GracePoint holds an exclusive tolling lease with the Aldama Merrill Crowe processing plant, including an option to purchase the company that controls the plant. The plant was completely refurbished in 2014, as a tolling facility, for the processing of local and regional ores and concentrates. The facility is in excellent condition, fully permitted, fully staffed, and immediately operational.

Additionally, the Joint Venture Agreement announced on November 7, 2016, has been terminated. All interest in the underlying project, the Cobriza Groupings, was returned to the previous owner.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.